Glixis Therapeutics Overview
- Year Founded
-
2012
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Glixis Therapeutics General Information
Description
Developer of novel therapies designed for autoimmune diseases. The company has engineered a pro-drug with a proprietary chemical structure that targets an underlying mechanism of progressive multiple sclerosis with secondary benefits to relapse and remit itself, enabling physicians to formulate a drug that can efficiently work for the smooth functioning between the brain and the body.
Contact Information
Website
www.glixis.comCorporate Office
- 122 Calistoga Road
- Suite 346
- Santa Rosa, CA 95409
- United States
Corporate Office
- 122 Calistoga Road
- Suite 346
- Santa Rosa, CA 95409
- United States
Glixis Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 14-Jan-2021 | Completed | Out of Business | |||
2. Grant | 12-Jun-2014 | Completed | Startup | |||
1. Accelerator/Incubator | Completed | Startup |
Glixis Therapeutics FAQs
-
When was Glixis Therapeutics founded?
Glixis Therapeutics was founded in 2012.
-
Where is Glixis Therapeutics headquartered?
Glixis Therapeutics is headquartered in Santa Rosa, CA.
-
What industry is Glixis Therapeutics in?
Glixis Therapeutics’s primary industry is Therapeutic Devices.
-
Is Glixis Therapeutics a private or public company?
Glixis Therapeutics is a Private company.
-
What is Glixis Therapeutics’s current revenue?
The current revenue for Glixis Therapeutics is
.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »